文献速递脑血管病

短暂性脑缺血发作或轻型缺血性卒中患者后续致残性或致死性卒中的风险:一项国际前瞻性队列研究

Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.
PubMed 文献 · Lancet Neurol · 2022-01-01

该国际前瞻性观察性注册研究纳入3847例短暂性脑缺血发作或轻型缺血性卒中患者,5年随访时3105例(80.7%)完成改良Rankin量表评估,710例(22.9%)mRS>1。多因素分析显示高龄、糖尿病、既往卒中/TIA史、高血压、房颤/房扑、充血性心力衰竭、瓣膜病、周围动脉病、冠心病、随访期颅内出血及独居与不良功能结局相关,病前规律体育锻炼与风险降低相关。

要点

  • 5年随访时22.9%(710/3105)患者mRS>1,残疾负担显著。
  • 病前规律体育锻炼者5年不良功能结局风险降低(OR 0.52,95%CI 0.42-0.66)。
  • 5年共345例复发性卒中,其中141例(40.9%)为致残性或致死性。

核心结论

  • 短暂性脑缺血发作或轻型缺血性卒中后5年存在显著的残疾负担(mRS>1),其多数预测因素为可干预的危险因素。
  • 病前规律体育锻炼的患者较不锻炼者5年残疾风险显著降低。

研究设计与样本

  • 国际前瞻性观察性注册研究(TIAregistry.org),纳入21个国家61个专科中心的短暂性脑缺血发作或轻型缺血性卒中患者。
  • 纳入标准:年龄≥18岁,2009年5月30日至2011年12月30日期间7天内发生短暂性脑缺血发作或轻型卒中,基线mRS评分0-1,且完成5年随访。
  • 共3847例 eligible 患者入组,其中3105例(80.7%)在5年随访时有mRS评估;中位随访时间5.00年(IQR 4.78-5.00)。
  • 采用多因素广义方程模型分析5年不良功能结局相关因素,采用多因素病因特异性Cox风险回归模型分析卒中复发。

主要发现

  • 5年时710/3105例(22.9%)mRS>1。
  • 5年不良功能结局相关因素:年龄每增加10岁OR 2.18(95%CI 1.93-2.46;p<0.0001);任何类型糖尿病OR 1.45(1.18-1.78;p=0.0001);入选事件前卒中或TIA史OR 1.74(1.37-2.22;p<0.0001);高血压OR 1.38(1.00-1.92;p=0.050);房颤或房扑OR 1.52(1.04-1.94;p=0.030);充血性心力衰竭OR 1.73(1.22-2.46;p=0.0024);瓣膜病OR 2.47(1.70-3.58;p<0.0001);以卒中为入选事件OR 1.31(1.09-1.57;p=0.0037);周围动脉病史OR 1.98(1.28-3.07;p=0.0023);冠心病史OR 1.32(1.00-1.74;p=0.049);随访期颅内出血OR 4.94(1.91-12.78;p=0.0013);独居OR 1.32(1.10-1.59;p=0.0031)。
  • 病前规律体育锻炼与5年不良功能结局风险降低相关(OR 0.52,95%CI 0.42-0.66;p<0.0001)。
  • 5年随访共发生345例复发性卒中,其中141例(40.9%)为致残性或致死性;卒中复发增加5年残疾风险(OR 3.52,95%CI 2.37-5.22;p<0.0001)。
  • 复发性致残或致死性卒中的独立相关因素:年龄每增加10岁HR 1.61(95%CI 1.35-1.92;p<0.0001);任何类型糖尿病HR 2.23(1.56-3.17;p<0.0001);出院时NIHSS>5 HR 5.11(2.15-12.13;p=0.0013);冠心病史HR 1.76(1.17-2.65;p=0.0063);入选事件前卒中或TIA史HR 1.54(1.03-2.29;p=0.035);充血性心力衰竭HR 1.86(1.01-3.47;p=0.044);以卒中为入选事件HR 1.73(1.22-2.45;p=0.0024);出院时mRS>1 HR 2.48(1.27-4.87;p=0.0083);随访期颅内出血HR 17.15(9.95-27.43;p<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients who have had a transient ischaemic attack or minor stroke have an increased risk of cardiovascular events for the following 5 years. We aimed to assess 5-year functional outcomes in patients with transient ischaemic attack or minor ischaemic stroke and to determine the factors associated with long-term disability. METHODS: We analysed data from patients in TIAregistry.org, an international, prospective, observational registry of patients with transient ischaemic attack or minor ischaemic stroke from 61 specialised centres in 21 countries. Patients aged 18 years or older who had a transient ischaemic attack or minor stroke within the previous 7 days between May 30, 2009, and Dec 30, 2011, with a baseline modified Rankin scale (mRS) score of 0-1, and who had been followed up for 5 years, were eligible for inclusion in this study. We evaluated whether existing comorbidities and stroke recurrence, categorised as disabling (mRS score of >1, including death) or non-disabling (mRS score of 0-1), at 5 years after baseline, were associated with poor functional outcome (defined as an mRS score of >1). We used multivariable generalised equation models for factors associated with poor functional outcome at 5 years and multivariable cause-specific Cox hazard regression models in case of stroke recurrence. FINDINGS: Between May 30, 2009, and Dec 30, 2011, 3847 eligible patients were included in the study, 3105 (80·7%) of whom had an mRS evaluation at 5 years of follow-up. Median follow-up duration was 5·00 years (IQR 4·78-5·00). 710 (22·9%) of 3105 patients had an mRS score greater than 1 at 5 years. Factors associated with poor functional outcome at 5 years were older age (per 10-year increase, odds ratio [OR] 2·18, 95% CI 1·93-2·46; p<0·0001), diabetes of any type (1·45, 1·18-1·78; p=0·0001), history of stroke or transient ischaemic attack before the qualifying event (1·74, 1·37-2·22; p<0·0001), hypertension (1·38, 1·00-1·92; p=0·050), atrial fibrillation or flutter (1·52, 1·04-1·94; p=0·030), congestive heart failure (1·73, 1·22-2·46; p=0·0024), valvular disease (2·47, 1·70-3·58; p<0·0001), stroke as qualifying event (1·31, 1·09-1·57; p=0·0037), history of peripheral artery disease (1·98, 1·28-3·07; p=0·0023), history of coronary artery disease (1·32, 1·00-1·74; p=0·049), intracranial haemorrhage during follow up (4·94, 1·91-12·78; p=0·0013), and living alone (1·32, 1·10-1·59; p=0·0031). Regular physical activity before the index event was associated with reduced risk of poor functional outcome (OR 0·52, 95% CI 0·42-0·66; p<0·0001). 345 recurrent strokes had occurred at 5 years of follow-up, 141 (40·9%) of which were disabling or fatal. Stroke recurrence increased the risk of having a disability at 5 years (OR 3·52, 95% CI 2·37-5·22; p<0·0001). Recurrent disabling or fatal strokes were independently associated with older age (per 10-year increase, hazard ratio [HR] 1·61, 95% CI 1·35-1·92; p<0·0001), diabetes of any type (2·23, 1·56-3·17; p<0·0001), National Institutes of Health Stroke Scale score of greater than 5 at discharge (5·11, 2·15-12·13; p=0·0013), history of coronary artery disease (1·76, 1·17-2·65; p=0·0063), history of stroke or transient ischaemic attack before the qualifying event (1·54, 1·03-2·29; p=0·035), congestive heart failure (1·86, 1·01-3·47; p=0·044), stroke as qualifying event (1·73, 1·22-2·45; p=0·0024), mRS score of greater than 1 at discharge (2·48, 1·27-4·87; p=0·0083), and intracranial haemorrhage during follow-up (17·15, 9·95-27·43; p<0·0001). Regular physical activity before the index event was associated with reduced risk of recurrent disabling stroke at 5 years (HR 0·56, 95% CI 0·31-0·99; p=0·046), and 5-year disability without recurrent stroke (0·61, 0·47-0·79; p=0·0001). INTERPRETATION: We found a substantial burden of disability (mRS score of >1) at 5 years after transient ischaemic attack or minor ischemic stroke, and most predictors of this disability were modifiable risk factors. Patients who did regular physical exercise before the index event had a significantly reduced risk of disability at 5 years compared with patients who did no exercise. FUNDING: AstraZeneca, Sanofi, Bristol Myers Squibb, SOS Attaque Cérébrale Association.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Hobeanu C, Lavallée PC, Charles H, et al. Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study. Lancet Neurol. 2022. PMID: 36115361. doi:10.1016/S1474-4422(22)00302-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。